Potentially Harmful Excipients: State of the Art for Oral Liquid Forms Used in Neonatology and Pediatrics Units

Marianne Bobillot,Violaine Delannoy,Alexandre Trouillard,Jean Marie Kinowski,Noelia Maria Sanchez-Ballester,Ian Soulairol

DOI: https://doi.org/10.3390/pharmaceutics16010119

IF: 6.525

2024-01-18

Pharmaceutics

Abstract:The pediatric population exhibits an important age-dependent heterogeneity in pharmacokinetics and pharmacodynamics parameters, resulting in differences in drug efficacy and toxicity compared to the adult population, particularly for neonates. Toxicity and efficacy divergences have been studied for active molecules, but the impact on the pharmacological parameters of excipients remains less well known. To fill this lack of knowledge, several initiatives have been started to gather information on the specific toxicity of excipients, such as the KIDS list or the STEP database. In order to contribute to this much-needed action, in this work, a compilation of the 219 formulations of oral liquid forms prescribed in pediatrics and neonatology units was established based on the summary of product characteristics. Then, for excipients found in more than 10% of the analyzed formulations, a review of their toxicity data was carried out using the STEP database. Finally, for a selection of 10 frequently used liquid forms, the amounts of excipients administered daily were calculated based on the recommended posology in the Summary of Product Characteristics (SPC) and compared with the recommended daily limits proposed by the European Medicine Agency. Pediatrics-adapted formulations are still rare, and it is not always possible to find safe alternatives to drugs containing excipients of interest.

pharmacology & pharmacy

What problem does this paper attempt to address?

The paper primarily explores the issue of potentially harmful excipients in oral liquid formulations used in pediatrics and neonatology. Specifically, the study aims to:

1. **Identify common excipient components**: By analyzing 219 oral liquid formulations used in pediatrics and neonatology, the study identifies the most frequently occurring excipient components.

2. **Assess the toxicity of excipients**: For those excipients present in more than 10% of the formulations, the study evaluates their potential toxicity to pediatric populations by consulting resources such as the STEP database and referencing the daily recommended intake levels set by the European Medicines Agency (EMA).

3. **Calculate actual intake levels**: The study selects 10 commonly used liquid formulations and calculates the actual daily intake of excipients based on the recommended doses in the Summary of Product Characteristics (SPC). These intake levels are then compared with the EMA's recommended daily intake limits to assess the risk of overconsumption.

In summary, the core objective of this paper is to better understand the safety issues related to excipients in pediatric and neonatal medications, particularly in oral liquid formulations. The study hopes to promote improvements in pediatric drug formulations to ensure the safety and efficacy of medications for children.